This move is archived. Current quotes and coverage live on the stock page.
Get CHLT alerts:
Custom Health Holdings Inc. experienced a notable uptick in its stock price following positive analyst coverage and strategic acquisitions.
Shares of Custom Health Holdings Inc. (CHLT.TO) surged by 7.85% yesterday, closing at CA$7.01. This increase was largely driven by a combination of favorable analyst ratings and significant business developments.
Investor takeaway: Investors should consider Custom Health's growth potential, especially in light of its recent acquisitions and the positive reception from analysts, which could signal further upside.
Advertisement
Custom Health Holdings Inc.
CHLT.TO
CHLT.TO
Custom Health Holdings Inc.
WealthAwesomeMarket cap
$186.12M
52W high
$11.00
52W low
$5.25
1W change
+5.26%
Analyst Price Targets
Based on analyst covering CHLT
Wall Street analysts forecast CHLT stock price to rise 66.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.00
+66.7% Upside
Current Price
C$7.20
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CHLT's historical volatility
30-Day Vol
69.4%
Annualized
90-Day Vol
98.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$6.02
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$6.78 | C$5.34 โ C$8.62 |
| 60 trading days | C$6.39 | C$4.56 โ C$8.97 |
| 90 trading days | C$6.02 | C$3.98 โ C$9.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
7.85% Surge
Custom Health's stock price increased by 7.85% yesterday, reflecting strong investor confidence following positive news.
Bull case
With a Buy rating from Stifel and a price target set at CA$12, Custom Health's innovative approach to medication adherence through its Spencer device positions it for substantial revenue growth and market penetration. Analysts believe that this technology could significantly improve patient outcomes, making it a compelling investment opportunity.
Bear case
Despite the positive momentum, Custom Health's current profit margin is negative, and the healthcare sector can be unpredictable, which may pose risks to sustained growth. Investors should be aware that market fluctuations and profitability challenges could impact the company's performance in the long run.
Analyst Ratings Drive Investor Confidence
Advertisement
Custom Health received a Buy rating from Stifel, with analysts projecting a price target of C$12. This endorsement highlights the company's innovative solutions for medication adherence, which are crucial in addressing significant healthcare challenges. Stifel's analysis suggests that Custom Health could see its active patient count nearly triple in the coming year, further enhancing its market position.
Strategic Acquisition of Evergreen Pharmacy
In a move to bolster its growth, Custom Health announced its intention to acquire Evergreen Pharmacy for US$3.5 million. This acquisition is expected to add over US$78 million in annual revenue, aligning with Custom Health's strategy to enhance its offerings for patients managing complex therapies. The deal is anticipated to close in the third quarter of 2026, further expanding Custom Health's footprint in the U.S. market.
Market Response and Future Outlook
The market responded positively to the news, with shares of Custom Health rising significantly. Investors are optimistic about the company's growth trajectory, especially given the increasing demand for effective medication management solutions. However, potential investors should remain cautious of the inherent risks in the healthcare sector, particularly regarding profitability and market fluctuations.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
